関連する実験動画
Updated: Aug 7, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
非中心的肥満は代謝的に無害ですか? 人口調査による予防への影響
1Department of Community Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
JAMA
|December 27, 1995
まとめ
腰と股関節の比率が低い全体的な肥満は,代謝的に安全ではありません. 体質指数 (BMI) は,代謝リスクの予測において,腰と腰の比 (WHR) と同等に重要であり,体重減少教育の必要性を強調しています.
科学分野:
- 心血管の健康についてです.
- メタボリックシンドロームとは
- 肥満に関する研究
背景:
- 高腰比率 (WHR) によって示される中心部肥満は,有害な代謝プロファイルと関連しています.
- 低WHRを有する個体における全体的な肥満 (ボディマス指数,BMIで測定される) の代謝的影響については,さらなる調査が必要である.
研究 の 目的:
- 全体的に肥満であるが腰と腰の比率が低い個人が,不利な脂質プロファイル,血圧,およびグルコース状態を示すかどうかを調査する.
- 代謝健康指標に関するBMIとWHRの予測力を比較する.
主な方法:
- マニトバ・ハート・ヘルス・サーベイから2,792人の成人 (18歳から74歳) を対象とした横断的な研究.
- 臨床検査には,血圧,断食プラズマグルコース,総コレステロール,トリグリセリド,HDL,LDLの測定が含まれていました.
- BMIとWHRのカテゴリー間の代謝変数を比較したデータを分析しました.
主要な成果:
- 非中心的肥満 (WHRが低い全体的な肥満) は,非肥満と中心的に肥満の個体間の中間的な代謝プロファイルを示しています.
- BMIとWHRは,ほとんどの代謝変数の有意な独立した予測指標です.
- 予測モデルでは,BMIがWHRよりも強い予測要因であったことが多い.
結論:
- 非中心的肥満は代謝的には良性ではなく,健康に重大なリスクをもたらす.
- 全体的な肥満 (BMI) は,代謝結果の予測において,中心的な肥満 (WHR) ほど重要で,時にはより重要である.
- 減量に重点を置く健康教育は,非中心的に肥満の個人に非常に重要です.
関連する概念動画
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

